Johnson & Johnson (FRA:JNJ)
135.34
+0.24 (0.18%)
Last updated: May 20, 2025
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€597,179
Profits / Employee
€145,800
Market Cap
325.88B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Energy AG | 98,000 |
Siemens Healthineers AG | 72,000 |
Johnson & Johnson News
- 15 hours ago - Moody's U.S. Debt Downgrade: Stocks Poised To Benefit - Seeking Alpha
- 16 hours ago - Market Whales and Their Recent Bets on JNJ Options - Benzinga
- 1 day ago - Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson's Biosense Webster Medical Technology Unit - Business Wire
- 3 days ago - Recent Filing Shows That Rep. Thomas Kean Bought Over $9K Worth of Amazon.com Stock - Benzinga
- 4 days ago - Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails - Wallstreet:Online
- 4 days ago - Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails - Business Wire
- 4 days ago - If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From Dividends You Would Have Today - 24/7 Wall street
- 5 days ago - From Cancer Drugs To Cosmetics: A Cash-strapped Company's Makeover Story - Benzinga